|
Treatment
Suissa and coworkers assessed the clinical relevance of the systemic effect of inhaled and nasal corticosteroids in a nested case-control study with the particular merit of carefully controlling for oral corticosteroid use. The authors found no evidence that the recommended doses of inhaled and nasal corticosteroids increased fracture risk and that the risk of hip fracture was only increased in long-term users of more than 2,000 µg/day of beclomethasone or equivalent.
1 Citation displayed.
Inhaled and Nasal Corticosteroid Use and the Risk of Fracture
- Samy Suissa, Marc Baltzan, Richard Kremer, and Pierre Ernst
Am. J. Respir. Crit. Care Med. 169: 83 -88. First published online as doi:10.1164/rccm.200305-640OC
[Abstract]
[Full text]
|
|
